Send Away Test for Oncotype DX Breast Recurrence Score
Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
Buyer
Gloucestershire Hospitals NHS Foundation Trust
Value
£214,650
Published
3 Feb 2026
Closes
3 Feb 2026
Procurement details
Source
Find a Tender
Region
Gloucestershire, Wiltshire and Bristol/Bath area
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85111800
Pathology services
Lots
Lot 1 Send Away Test for Oncotype DX Breast Recurrence Score
£214,650
This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. <br/>This contract has been awarded under Direct Award A <br/>The lifetime value of this contract is £214,650 <br/>The contract is in place from 1st July 2...
Delivery: Gloucestershire
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.